Champions Oncology (CSBR) Operating Leases (2019 - 2025)
Historic Operating Leases for Champions Oncology (CSBR) over the last 7 years, with Q4 2025 value amounting to $5.3 million.
- Champions Oncology's Operating Leases fell 2222.88% to $5.3 million in Q4 2025 from the same period last year, while for Oct 2025 it was $5.3 million, marking a year-over-year decrease of 2222.88%. This contributed to the annual value of $4.6 million for FY2025, which is 2394.55% down from last year.
- Latest data reveals that Champions Oncology reported Operating Leases of $5.3 million as of Q4 2025, which was down 2222.88% from $5.8 million recorded in Q3 2025.
- Champions Oncology's 5-year Operating Leases high stood at $9.2 million for Q3 2022, and its period low was $4.6 million during Q2 2025.
- In the last 5 years, Champions Oncology's Operating Leases had a median value of $7.9 million in 2023 and averaged $7.5 million.
- In the last 5 years, Champions Oncology's Operating Leases surged by 17706.62% in 2021 and then tumbled by 2394.55% in 2025.
- Champions Oncology's Operating Leases (Quarter) stood at $8.5 million in 2021, then grew by 5.16% to $9.0 million in 2022, then decreased by 10.21% to $8.0 million in 2023, then fell by 15.84% to $6.8 million in 2024, then fell by 22.23% to $5.3 million in 2025.
- Its last three reported values are $5.3 million in Q4 2025, $5.8 million for Q3 2025, and $4.6 million during Q2 2025.